In prostate cancer, the silencing of ITGB4 reduces the ability of tumor progenitor cells to self-renew in vitro, suggesting that ITGB4 signaling may play a critical role in maintaining CSCs within the tumor [39]. The gene discussed is ITGB4; the disease is neoplasm.